(Q43818097)

English

A randomized, double-blind, placebo-controlled study of itraconazole capsules for the prevention of deep fungal infections in immunodeficient patients with HIV infection

scientific article published in April 2001

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

A randomized, double-blind, placebo-controlled study of itraconazole capsules for the prevention of deep fungal infections in immunodeficient patients with HIV infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

prevention of HIV/AIDS

0 references

1 reference

based on heuristic

inferred from title

author name string

D E Smith

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

J Bell

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M Johnson

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M Youle

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

B Gazzard

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

S Tchamouroff

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

G Frechette

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

W Schlech

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

S Miller

9

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

D Spencer

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

W Seifert

11

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M Peeters

12

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

K De Beule

13

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Itraconazole Prophylaxis Study Group

14

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 April 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

78-83

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Oral azole drugs as systemic antifungal therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00060.X

21 January 2018

Pharmacokinetics of itraconazole following oral administration to normal volunteers

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00060.X

21 January 2018

Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00060.X

21 January 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00060.X

21 January 2018

Decline in deaths from AIDS due to new antiretrovirals

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00060.X

21 January 2018

Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00060.X

21 January 2018

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00060.X

21 January 2018

Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00060.X

21 January 2018

Successful Chemoprophylaxis forPneumocystis cariniiPneumonitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00060.X

21 January 2018

The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00060.X

21 January 2018

Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00060.X

21 January 2018

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00060.X

21 January 2018

Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00060.X

21 January 2018

Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00060.X

21 January 2018

Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00060.X

21 January 2018

Pharmacology of itraconazole

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00060.X

21 January 2018

Identifiers

10.1046/J.1468-1293.2001.00060.X

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43818097&oldid=2103618857"